1. Home
  2. CTKB vs LXRX Comparison

CTKB vs LXRX Comparison

Compare CTKB & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.54

Market Cap

582.3M

Sector

Health Care

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.83

Market Cap

660.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
LXRX
Founded
1990
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.3M
660.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
CTKB
LXRX
Price
$4.54
$1.83
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$5.63
$4.15
AVG Volume (30 Days)
489.1K
2.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
$193,015,000.00
$49,803,000.00
Revenue This Year
$5.42
N/A
Revenue Next Year
$7.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.67
60.24
52 Week Low
$2.37
$0.51
52 Week High
$6.18
$1.95

Technical Indicators

Market Signals
Indicator
CTKB
LXRX
Relative Strength Index (RSI) 51.58 62.13
Support Level $4.00 $1.07
Resistance Level $4.60 N/A
Average True Range (ATR) 0.17 0.09
MACD 0.01 0.02
Stochastic Oscillator 43.69 76.74

Price Performance

Historical Comparison
CTKB
LXRX

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: